Variable | Groups | Severe patients (N = 46) | Non-Severe patients (N = 46) | |
---|
Gender (N,%) | Male Female | 23(50%) 23(50%) | 23(50%) 23(50%) | |
Age (N, %) | ≤40 40< | 10(21.7%) 36(78.26%) | 10(21.7%) 22(78.26%) | |
Age (Mean ± SD) | | 47.78 ± 11.83 | 49.55 ± 15.67 | |
Weight (Mean ± SD) | Male Female | 73.32 ± 10.32 70 ± 11.31 | 74.21 ± 11.65 71.42 ± 11.12 | |
Fever | Yes No | 32(69.56%) 14(30.44%) | 27(58.69%) 19(41.31%) | |
Dyspnea | Yes No | 26(56.52%) 20(43.48%) | 24(52.17%) 22(47.83%) | |
Cough | Yes No | 36(78.26%) 10(21.7%) | 25(54.34%) 24(45.46%) | |
Sore throat | Yes No | 33(71.73%) 13(28.28%) | 27(58.69%) 19(41.31%) | |
Myalgia | Yes No | 31(67.39%) 15(32.61%) | 21(45.65%) 25(54.35%) | |
Headache | Yes No | 20(43.48%) 26(56.52%) | 17(36.95%) 29(63.04%) | |
Tiredness | Yes No | 34(73.91%) 12(26.09%) | 24(52.17%) 22(47.83%) | |
Diarrhea | Yes No | 11(23.91%) 35(76.09%) | 2(4.34%) 44(95.65%) | |
Vomiting | Yes No | 9(19.56%) 37(80.43%) | 4(8.69%) 42(91.30%) | |
- ** The table presents demographic features of the enrolled patients categorized as severe (N = 46) and non-severe (N = 46) for SARS-CoV-2 infection. Gender distribution, age groups, mean age, and the presence of symptoms such as fever, dyspnea, cough, sore throat, myalgia, headache, tiredness, diarrhea, and vomiting are outlined
- Gender distribution shows an equal split between male and female patients in both severe and non-severe groups
- Age distribution indicates a higher proportion of patients aged 40 and above in both severity categories
- Fever, cough, sore throat, myalgia, and tiredness were common symptoms reported by patients, with varying prevalence between severe and non-severe cases
- Dyspnea, headache, diarrhea, and vomiting were also noted, with differences in occurrence between severe and non-severe groups
- Mean age was slightly higher in the non-severe group compared to the severe group
- These demographic features offer insights into the clinical profile of patients enrolled in the study, highlighting key characteristics relevant to disease severity assessment
- Analysis methods for each entry in the table include statistical tests for group comparisons and descriptive statistics for demographic variables